The antidepressant effects of GM-CSF are mediated by the reduction of TLR4/NF-ĸB-induced IDO expression

GM-CSF producing autoreactive CD4 + T cells in type 1 diabetes

(2018) Jan Knoop et al.   CLINICAL IMMUNOLOGY

Evidence of the impact of systemic inflammation on neuroinflammation from a non-bacterial endotoxin animal model

(2018) Chunxia Huang et al.   Journal of Neuroinflammation

Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder

(2018) Ebrahim Haroon et al.   PSYCHONEUROENDOCRINOLOGY

Granulocyte-macrophage colony-stimulating factor improves mouse peripheral nerve regeneration following sciatic nerve crush

(2018) André Luis Bombeiro et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Inflammation in Depression and the Potential for Anti-Inflammatory Treatment

(2016) Ole Kohler et al.   Current Neuropharmacology

GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation

(2016) Burkhard Becher et al.   IMMUNITY

Intracerebral GM-CSF contributes to transendothelial monocyte migration in APP/PS1 Alzheimer’s disease mice

(2016) De S Shang et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Kynurenine metabolic balance is disrupted in the hippocampus following peripheral lipopolysaccharide challenge

(2016) Jennifer M. Parrott et al.   Journal of Neuroinflammation

Inflammation and increased IDO in hippocampus contribute to depression-like behavior induced by estrogen deficiency

(2015) Yongjun Xu et al.   BEHAVIOURAL BRAIN RESEARCH

Granulocyte macrophage colony-stimulating factor treatment results in recovery of motor function after white matter damage in mice

(2015) Jennifer K. Theoret et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity

(2015) Andrew L. Croxford et al.   IMMUNITY

G-CSF and GM-CSF in Neutropenia

(2015) Hrishikesh M. Mehta et al.   JOURNAL OF IMMUNOLOGY

Granulocyte-Macrophage Colony Stimulating Factor Exerts Protective and Immunomodulatory Effects in Cortical Trauma

(2015) Matthew L. Kelso et al.   JOURNAL OF NEUROIMMUNOLOGY

GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage

(2015) Andrew L. Croxford et al.   TRENDS IN IMMUNOLOGY

The Forced Swim Test as a Model of Depressive-like Behavior

(2015) Roni Yankelevitch-Yahav et al.   Jove-Journal of Visualized Experiments

Oxidative Stress and Psychological Disorders

(2014) Samina Salim   Current Neuropharmacology

Correction: Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers

(2014) Mohammad-Ali Jenabian et al.   PLoS One

Quinolinic Acid: Neurotoxin or Oxidative Stress Modulator?

(2013) Lenka Kubicova et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice

(2013) Lisa M. Kosloski et al.   JOURNAL OF NEUROIMMUNOLOGY

Granulocyte macrophage colony-stimulating factor promotes regeneration of retinal ganglion cells in vitro through a mammalian target of rapamycin-dependent mechanism

(2013) Jacqueline Legacy et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Granulocyte Macrophage Colony-Stimulating Factor Shows Anti-apoptotic Activity via the PI3K–NF-κB–HIF-1α–Survivin Pathway in Mouse Neural Progenitor Cells

(2013) Jung Kyoung Choi et al.   MOLECULAR NEUROBIOLOGY

The Role of Oxidative Stress in Depressive Disorders

(2012) Tanja Maria Michel et al.   CURRENT PHARMACEUTICAL DESIGN

GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia

(2012) Bijay Parajuli et al.   Journal of Neuroinflammation

Treatment-resistant depression: therapeutic trends, challenges, and future directions

(2012) Al-harbi   Patient Preference and Adherence

The hematopoietic cytokine granulocyte-macrophage colony stimulating factor is important for cognitive functions

(2012) Markus Krieger et al.   Scientific Reports

Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: Multiplex quantification with path analysis

(2011) Michelle A. Erickson et al.   BRAIN BEHAVIOR AND IMMUNITY

Granulocyte macrophage-colony stimulating factor protects against substantia nigra dopaminergic cell loss in an environmental toxin model of Parkinson's disease

(2011) E.N. Mangano et al.   NEUROBIOLOGY OF DISEASE

GM-CSF Signalling Boosts Dramatically IL-1Production

(2011) Hanif Javanmard Khameneh et al.   PLoS One

LPS inhibits the effects of fluoxetine on depression-like behavior and hippocampal neurogenesis in rats

(2011) Ying Wang et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats

(2011) Mohammed Emamussalehin Choudhury et al.   Brain and Behavior

Central Administration of Lipopolysaccharide Induces Depressive-like Behavior in Vivo and Activates Brain Indoleamine 2,3 Dioxygenase In Murine Organotypic Hippocampal Slice Cultures

(2010) Xin Fu et al.   Journal of Neuroinflammation

Intracerebral granulocyte-macrophage colony-stimulating factor induces functionally competent dendritic cells in the mouse brain

(2009) Anne Kathrin Mausberg et al.   GLIA

Treatment with granulocyte–macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock

(2009) Joerg C. Schefold et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

GM-CSF inhibits glial scar formation and shows long-term protective effect after spinal cord injury

(2008) Xian Huang et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression

(2008) Michael Maes et al.   METABOLIC BRAIN DISEASE

Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice

(2008) J C O'Connor et al.   MOLECULAR PSYCHIATRY

Marked increases in hippocampal neuron indoleamine 2, 3-dioxygenase via IFN-γ-independent pathway following transient global ischemia in mouse

(2008) Masato Hoshi et al.   NEUROSCIENCE RESEARCH